Tuesday [24/5/22] Flashcards
(100 cards)
What is Budd-Chiari? [1]
Budd-Chiari syndrome, or hepatic vein thrombosis, is usually seen in the context of underlying haematological disease or another procoagulant condition.
Causes of Budd-Chiari [4]
polycythaemia rubra vera
thrombophilia: activated protein C resistance, antithrombin III deficiency, protein C & S deficiencies
pregnancy
combined oral contraceptive pill: accounts for around 20% of cases
Features of Budd-Chiari [3]
abdominal pain: sudden onset, severe
ascites → abdominal distension
tender hepatomegaly
Ix for Budd-Chiari [1]
ultrasound with Doppler flow studies is very sensitive and should be the initial radiological investigation
What is carcinoid syndrome? [2]
usually occurs when metastases are present in the liver and release serotonin into the systemic circulation
may also occur with lung carcinoid as mediators are not ‘cleared’ by the liver
Features of carcinoid tumours
flushing (often earliest symptom)
diarrhoea
bronchospasm
hypotension
right heart valvular stenosis (left heart can be affected in bronchial carcinoid)
other molecules such as ACTH and GHRH may also be secreted resulting in, for example, Cushing’s syndrome
pellagra can rarely develop as dietary tryptophan is diverted to serotonin by the tumour
Ix for carcinoid tumours [2]
urinary 5-HIAA
plasma chromogranin A y
Mx for carcinoid tumours [2]
somatostatin analogues e.g. octreotide
diarrhoea: cyproheptadine may help
How does cholestyramine work? [2]
Cholestyramine is a bile acid sequestrant used in the management of hyperlipidaemia. It decreases bile acid reabsorption in the small intestine, therefore upregulating the amount of cholesterol that is converted to bile acid. The main effect it has on the lipid profile is to reduce LDL cholesterol. It is also occasionally used in Crohn’s disease for treatment diarrhoea following bowel resection
Adverse effects of cholestyramine [4]
abdominal cramps and constipation
decreases absorption of fat-soluble vitamins
cholesterol gallstones
may raise level of triglycerides
Type of bug is C. diff
Clostridium difficile is a Gram positive rod often encountered in hospital practice.
Pathogenesis of C. diff
It produces an exotoxin which causes intestinal damage leading to a syndrome called pseudomembranous colitis. Clostridium difficile develops when the normal gut flora are suppressed by broad-spectrum antibiotics
What typically causes C.diff? [3]
Clindamycin is historically associated with causing Clostridium difficile but the aetiology has evolved significantly over the past 10 years. Second and third generation cephalosporins are now the leading cause of Clostridium difficile.
Other than antibiotics, risk factors include:
proton pump inhibitors
Features of C.diff [4]
Features diarrhoea abdominal pain a raised white blood cell count (WCC) is characteristic if severe toxic megacolon may develop
Mild C.diff [1]
Normal WCC
Moderate C.diff [2]
↑ WCC ( < 15 x 109/L)
Typically 3-5 loose stools per day
Severe C.diff [3]
↑ WCC ( > 15 x 109/L)
or an acutely ↑ creatinine (> 50% above baseline)
or a temperature > 38.5°C
or evidence of severe colitis(abdominal or radiological signs)
Life threatening C.diff [3]
Hypotension
Partial or complete ileus
Toxic megacolon, or CT evidence of severe disease
Dx of C.diff [2]
is made by detecting Clostridium difficile toxin (CDT) in the stool
Clostridium difficile antigen positivity only shows exposure to the bacteria, rather than current infection [2]
First-line Mx of C.diff [3]
First episode of Clostridium difficile infection
- first-line therapy is oral vancomycin for 10 days
- second-line therapy: oral fidaxomicin
- third-line therapy: oral vancomycin +/- IV metronidazole
Recurrent episode of C.diff Mx [3]
- recurrent infection occurs in around 20% of patients, increasing to 50% after their second episode
- within 12 weeks of symptom resolution: oral fidaxomicin
- after 12 weeks of symptom resolution: oral vancomycin OR fidaxomicin
Life-threatening C.diff Mx [2]
oral vancomycin AND IV metronidazole
specialist advice - surgery may be considered
Other therapies for C.diff [3]
bezlotoxumab is a monoclonal antibody which targets Clostridium difficile toxin B
NICE do not currently support its use to prevent recurrences as it is not cost-effective
faecal microbiota transplant
may be considered for patients who’ve had 2 or more previous episodes
Coeliac disease is an autoimmune condition to what?
Gluten